The honest bottom line is that BPC-157 is a lab-made peptide, not an approved medicine. Its name stands for Body Protection Compound 157, and its sequence traces to a region of a larger protein reported in human gastric juice, yet the free fifteen-residue fragment is produced by chemical synthesis rather than extracted from tissue. The published record on it is dominated by laboratory and animal work, and major drug regulators have granted it no marketing authorization for human therapeutic use.
BPC-157 is a synthetic 15-amino-acid peptide patterned on a fragment of a human gastric protective protein, first appearing in the scientific literature in the 1990s, and it holds no marketing authorization from major drug regulators.
The term pentadecapeptide simply records the count, fifteen residues in a single linear chain, far below the size at which a protein folds into a stable shape. What the literature most often highlights is a run of three consecutive proline residues near the N-terminus, the structural feature associated with the compound's reported resistance to breakdown in acidic conditions.
BPC-157 is a single linear chain of fifteen amino acid residues with the sequence GEPPPGKPADDAGLV, a molecular formula commonly cited as C62H98N16O22 and a molecular weight near 1419 daltons.
The name points back to a larger protein that researchers reported finding in human gastric juice, associated with the stomach lining's defense against acid and irritants. BPC-157 is not that whole protein; the published descriptions treat it as a specific region of the parent molecule, narrowed down to the short fragment that appeared to carry the protective signal and refined into a defined fifteen-residue peptide for study.
BPC-157 corresponds to a partial sequence of a larger protective protein reported in human gastric juice, refined into a defined fifteen-residue fragment rather than representing the whole parent molecule.
The accurate framing separates the sequence from the molecule: the amino acid string is biological in origin, but the free fifteen-residue peptide is a synthetic construct. Nothing in normal physiology cleaves the parent gastric protein into exactly that free fragment for use as a signaling molecule, which is why calling BPC-157 a naturally occurring substance overstates the case.
BPC-157 is a lab-made peptide modeled on a sequence found within a natural gastric protein, and there is no robust evidence that the free fifteen-residue peptide occurs or circulates on its own in the human body.
The body of work emerged from gastroenterology research in the 1990s and is closely tied to a research group based in Croatia, with the University of Zagreb medical faculty frequently named in the early and continuing studies. A relevant detail when weighing the evidence is how concentrated the literature is: a large share of the published studies share overlapping authorship from that same group, so independent replication from unrelated laboratories carries extra weight.
BPC-157 emerged from 1990s gastroenterology research tied to a Croatian group associated with the University of Zagreb medical faculty, and a large share of its published studies share overlapping authorship from that same network.
BPC-157 is built by chemical synthesis, not extracted from tissue, because the free peptide does not occur on its own and synthesis gives a defined, reproducible sequence at scale. The detail that matters for anyone reading a vendor's specifications is regulatory: most material on the market is labeled research-use-only, meaning it is not made under pharmaceutical good manufacturing practice and no approving authority verifies each batch.
BPC-157 is manufactured by solid-phase peptide synthesis and purified by high-performance liquid chromatography, but most market material is labeled research-use-only and is not produced under pharmaceutical good manufacturing practice, so batch potency, purity, and identity can vary between sellers.
BPC-157 holds no marketing approval as a medicine from major drug regulators and has not completed the clinical-trial pathway an approved therapeutic would require. Several bodies have addressed it directly, and the through-line is its research-use-only character: a compound supplied for laboratory study, lacking an approval dossier, does not enter the prescribing and dispensing channels that govern licensed drugs.
BPC-157 holds no marketing approval from major drug regulators, has been flagged by the FDA in the compounding context and treated as not a lawful dietary ingredient, and is listed by the World Anti-Doping Agency among prohibited substances.
In both supply catalogs and study protocols, BPC-157 most commonly appears as a lyophilized, freeze-dried white powder, because removing water leaves the peptide far more stable for shipping and storage than a ready-made solution. The freeze-dried vial is the reference form around which the published handling instructions are written; other advertised presentations sit in the same unapproved space, with content and stability not verified by any regulatory authority.
BPC-157 is most commonly supplied and described as a lyophilized freeze-dried powder reconstituted with a diluent such as bacteriostatic water, with the freeze-dried vial serving as the reference form around which published handling and stability instructions are written.
Educational use only. This article describes what the published scientific and clinical literature reports about BPC-157. It is not medical advice, and it does not recommend, prescribe, or tell anyone to use anything described here. The regulatory status shown at the top of this page reflects what the record showed on the date given there and can change. mdpep.com does not sell any substance described here, does not endorse human use of it, and does not direct anyone to obtain it.
This is not guidance for your situation. Nothing here accounts for your medical history, your current medications, or anything else specific to you, and none of it should be used to make a decision about your own health.
Affiliate disclosure. Some links on this site are affiliate links, and mdpep.com may earn a commission when they are used. That never affects what is written here, it is not an endorsement of any vendor, and it is not a statement that anything described on this page is available to buy.
Every claim here ties to a named primary source and a date, written as plain documentation with nothing for sale. That is how MD PEP covers the whole peptide market.
